VYOME HOLDINGS, INC. Restructuring Reserve
VYOME HOLDINGS, INC. (HIND) had Restructuring Reserve of $0 as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2021-03-12
- 2020-12-31: Restructuring Reserve $0.00.
- 2019-12-31: Restructuring Reserve $280.00K.
- 2019-09-30: Restructuring Reserve $424.00K.
- 2019-06-30: Restructuring Reserve $568.00K.
| Period end | Restructuring Reserve |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2019-12-31 | $280.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $424.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $568.00K 10-Q · filed 2019-11-08 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |